Quality Assessment: Strong Fundamentals and Operational Efficiency
CRISIL’s quality metrics remain robust, underpinning the upgrade. The company boasts a high return on equity (ROE) of 27.03% and a return on capital employed (ROCE) of 40.16%, reflecting efficient capital utilisation and strong profitability. Management efficiency is further highlighted by a net-debt-free balance sheet, which reduces financial risk and enhances operational flexibility.
Recent financial results for the first quarter of FY26-27 reinforce this strength. Net sales for the latest six months stood at ₹2,133.05 crores, marking a growth of 28.79% year-on-year. Profit after tax (PAT) surged by 35.70% to ₹449.72 crores, while profit before tax less other income (PBT less OI) rose 28.43% to ₹258.70 crores. These figures demonstrate the company’s ability to sustain growth and profitability amid a challenging macroeconomic environment.
However, a note of caution arises from the company’s long-term sales growth, which has averaged 14.40% annually over the past five years. While respectable, this moderate pace suggests that investors should temper expectations for explosive expansion in the near term.
Valuation: Elevated but Justified by Performance
CRISIL’s valuation has shifted from expensive to very expensive, reflecting the market’s recognition of its quality and growth prospects. The price-to-earnings (PE) ratio currently stands at 39.92, significantly higher than peers such as CARE Ratings (29.28) and ICRA (24.13). Similarly, the price-to-book value ratio is elevated at 10.79, indicating a premium valuation relative to the company’s net assets.
Enterprise value multiples also underscore this premium stance: EV to EBIT is 32.14, EV to EBITDA is 28.25, and EV to capital employed is 12.91. The PEG ratio of 1.85 suggests that while the stock is expensive, its price growth is somewhat aligned with earnings growth, which has been robust at 21.5% over the past year.
Dividend yield remains modest at 1.31%, consistent with the company’s focus on reinvestment and growth rather than high payout. Investors should weigh the premium valuation against the company’s strong fundamentals and growth trajectory when considering entry points.
Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!
- - Rigorous evaluation cleared
- - Expert-backed selection
- - Mid Cap conviction pick
Financial Trend: Consistent Growth Amid Market Volatility
CRISIL’s financial trend remains positive, supported by strong quarterly results and a net-debt-free status. The company’s sales and profit growth in the latest six months outpace many peers, signalling operational resilience. Over the past year, the stock has delivered a return of -2.99%, slightly underperforming the Sensex’s -3.57%, but its earnings growth of 21.5% suggests improving fundamentals that may drive future price appreciation.
Longer-term returns are impressive, with a five-year stock return of 77.03% compared to the Sensex’s 33.72%, and a three-year return of 21.42% versus the Sensex’s 18.70%. However, the ten-year return of 120.02% trails the Sensex’s 170.48%, indicating periods of relative underperformance that investors should consider.
The company’s PEG ratio of 1.85 reflects a balance between valuation and growth, suggesting that while the stock is priced richly, its earnings trajectory justifies the premium to some extent.
Technicals: Bullish Momentum Drives Upgrade
The most significant driver behind the upgrade is the improvement in technical indicators, which have shifted from mildly bullish to bullish overall. Key weekly technical signals are positive: the Moving Average Convergence Divergence (MACD) is bullish on a weekly basis, Bollinger Bands indicate bullish momentum both weekly and monthly, and the daily moving averages confirm an upward trend.
Other technical indicators such as the Know Sure Thing (KST) oscillator and Dow Theory signals are mildly bullish on a weekly and monthly basis, reinforcing the positive momentum. The On-Balance Volume (OBV) indicator shows a bullish trend monthly, suggesting accumulation by investors.
Despite some bearish signals on monthly MACD and KST, the overall technical picture supports a constructive outlook. The stock’s recent price action, with a day change of +2.11% and a current price of ₹4,827.40, approaching its 52-week high of ₹5,111.15, reflects growing investor interest and confidence.
Thinking about CRISIL Ltd.? Our real-time Verdict report breaks down everything – from financial health and peer comparison to technical signals and fair valuation for this small-cap stock!
- - Real-time Verdict available
- - Financial health breakdown
- - Fair valuation calculated
Comparative Industry Position and Market Capitalisation
CRISIL operates within the capital markets sector, specifically in the ratings industry, where it competes with peers such as CARE Ratings and ICRA. Its valuation metrics are at the higher end of the spectrum, with a very expensive rating compared to CARE’s very expensive and ICRA’s expensive grades. This premium is supported by CRISIL’s superior ROCE and ROE figures, as well as its consistent financial performance.
The company is classified as a small-cap stock, which may appeal to investors seeking growth opportunities in less mature market segments. Its recent outperformance relative to the Sensex over shorter time frames — with a 1-week return of 7.97% versus Sensex’s -0.53%, and a 1-month return of 10.61% versus Sensex’s -1.46% — highlights its momentum and potential for further gains.
Risks and Considerations
Despite the positive outlook, investors should be mindful of certain risks. The company’s valuation is stretched, with a PE ratio nearing 40 and a price-to-book ratio above 10, which could limit upside if growth slows or market sentiment shifts. Additionally, the moderate long-term sales growth rate of 14.40% may constrain earnings expansion over time.
Technical indicators, while largely bullish, show some mixed signals on monthly charts, suggesting that investors should monitor momentum closely. Furthermore, the stock’s recent one-year return of -2.99% indicates some volatility and potential short-term headwinds.
Overall, the upgrade to Buy reflects a balanced view that recognises CRISIL’s strong fundamentals, improving technicals, and premium valuation, while acknowledging the need for cautious optimism given market dynamics.
Conclusion
CRISIL Ltd.’s upgrade from Hold to Buy by MarketsMOJO is underpinned by a confluence of factors: strong quality metrics with high ROE and ROCE, robust financial trends marked by significant sales and profit growth, a very expensive yet justified valuation, and a bullish shift in technical indicators. The company’s net-debt-free status and consistent operational performance further bolster its investment appeal.
Investors looking for exposure to the capital markets sector may find CRISIL an attractive proposition, especially given its recent outperformance relative to the broader market and peers. However, the elevated valuation and mixed long-term growth signals warrant careful monitoring. The upgrade signals confidence in CRISIL’s near-term prospects and technical momentum, making it a compelling candidate for inclusion in growth-oriented portfolios.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
